Indegene Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Indegene Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W Low on Jun 04, 2024
27
TTM PE Ratio
Price to Book Ratio
High in industry
9.6
Dividend yield 1yr %
0
TTM PEG Ratio
RSI
RSI is mid-range
53.4
MFI
MFI Overbought
75.2

Indegene Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Indegene Ltd shareholding Pattern

Foreign Institutions
3.6%
Mutual Funds
2.3%
Domestic Institutions
5.3%
Public
90.9%

Indegene Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
1
5Day EMA
570.20
10Day EMA
567.10
12Day EMA
565.50
20Day EMA
560.50
26Day EMA
552.90
EMA
NaN
EMA
NaN
EMA
NaN
5Day SMA
567.50
10Day SMA
575.00
20Day SMA
550.40
30Day SMA
548.80
SMA
NaN
SMA
NaN
SMA
NaN
SMA
NaN
Delivery & Volume
Resistance & Support
577.35
Pivot
Resistance
First Resistance
586.40
Second Resistance
598.70
Third Resistance
607.75
Support
First Support
565.05
Second support
556
Third Support
543.70
Relative Strength Index
53.40
Money Flow Index
75.16
MACD
0.00
MACD Signal
0.00
Average True Range
23.79
Average Directional Index
32.27
Rate of Change (21)
8.53
Rate of Change (125)
0.00
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
AstraZeneca Pharma India Ltd.
15798.75
3650.05
7208
Caplin Point Laboratories Ltd.
10649.31
781.25
1617.8
Granules India Ltd.
11814.26
283.1
498.85
Jubilant Pharmova Ltd.
11562.79
319.3
770.65
Sanofi India Ltd.
15656.72
5850.55
10526.05
Eris Lifesciences Ltd.
13814.09
660
1066

Indegene Ltd Company background

Founded in: 1998
Indegene Ltd was incorporated as Indegene Lifesystems Private Limited at Ahmedabad, Gujarat, as a Private Limited Company, datedOctober 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited and a fresh certificate of incorporation was issued to Company by RoC, on November 17, 2022.The Company is a digitalfirst commercialization company focused exclusively on the global life sciences industry. Their solutionsenable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, anddrive sales through their life cycle in a more effective, efficient and modern manner. Their portfolio of solutions cover all aspects ofcommercial, medical, regulatory and RD operations of life sciences companies. Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a digital first approach for optimizing the lastmile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analyticsin helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies. In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.The Company acquired Cult Health, a fullservice healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.The Company is planning to raise capital from Public by raising Rs 950 crores through fresh issue and 36,291,497 Equity Shares through Offer For Sale.
Read More

Indegene Ltd FAQs

The past 1-year return of Indegene Ltd [INDGN] share was 0. The Indegene Ltd [INDGN] share hit a 1-year low of Rs. 468.9 and a 1-year high of Rs. 659.7.

The Mutual Fund Shareholding was 2.28% at the end of .

You can easily buy Indegene Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage